Antithrombotic strategy according to age in patients with atrial fibrillation and drug-eluting stents: a post hoc analysis of the ADAPT AF-DES randomised trial.
Evidence for non-vitamin K antagonist oral anticoagulant (NOAC) monotherapy for older patients with atrial fibrillation (AF) and drug-eluting stents is lacking. We aimed to evaluate the safety and efficacy of NOAC monotherapy in older AF patients with drug-eluting stents. This is
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.